Creatine kinase (CK) is an enzyme that plays a crucial role in cellular energy homeostasis. It catalyzes the reversible transfer of a phosphate group from adenosine triphosphate (ATP) to creatine, forming phosphocreatine and adenosine diphosphate (ADP). This reaction is vital for the rapid regeneration of ATP, especially in tissues with high and fluctuating energy demands such as skeletal muscle, cardiac muscle, and the brain.
Creatine kinase exists in three isoenzymatic forms:
The CK-MB isoenzyme is of particular clinical interest because it serves as a biomarker for myocardial injury, such as that occurring during a heart attack.
Recombinant human creatine kinase MB isoenzyme (r-hCK-MB) is produced using recombinant DNA technology. This involves the insertion of cDNAs encoding the CK-M and CK-B subunits into a plasmid vector, which is then transformed into a host organism, typically Escherichia coli. The host organism expresses the CK-MB isoenzyme, which can then be purified for various applications.
The production of r-hCK-MB involves several steps:
Recombinant human CK-MB isoenzyme has several important applications: